Patent Assignment
Reel/Frame 047708/0469
Assignment of Assignor's Interest
Recorded: 2018-11-30
Pages: 9
Assignor
EUTHYMICS BIOSCIENCE, INC.
Executed: 2015-03-02
Assignee
NEUROVANCE, INC.
508 CARNEGIE CENTER DRIVE, PRINCETON, NEW JERSEY, 08540
Covered Properties
(2)
Use of (1R,5S)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
Application:
61/574,231 →
Use of (1R,5S)-(+)-1-(Naphthalen-2-Yl)-3-Azabicyclo{3.1.0}Hexane in the Treatment of Conditions Affected by Monoamine Neurotransmitters
PCT:
PCT/US2012/000335 ↗
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 30, 2018
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 047708/0147 →
Assignment of Assignor's Interest
Nov 30, 2018
From: MCKINNEY, ANTHONY ALEXANDER; BYMASTER, FRANK
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 047708/0151 →
Merger
Nov 30, 2018
From: NEUROVANCE, INC.
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 047708/0514 →